Growth retardation - An unexpected outcome from growth hormone gene therapy in normal mice with microencapsulated myoblasts

Human Gene Therapy

Volumn 7, Issue 1, 1996, Pages 61-70

  Al Hendy, Ayman ^a   Hortelano, Gonzalo ^a   Tannenbaum, Gloria S ^b   Chang, Patricia L ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; GROWTH HORMONE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY HEIGHT; BODY WEIGHT; BONE GROWTH; CONTROLLED STUDY; FEMALE; GENE THERAPY; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; GROWTH PLATE; GROWTH RETARDATION; HYPOPHYSIS FUNCTION; MALE; MICROCAPSULE; MICROENCAPSULATION; MOUSE; MYOBLAST; NONHUMAN; ORGAN WEIGHT; PITUITARY DWARFISM; WEIGHT REDUCTION;

EID: 0029996204     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.1-61     Document Type: Article

References (37)

1. AL-HENDY, A., HORTELANO, G., TANNENBAUM, G.S., and CHANG P.L. (1995). Correction of the growth defect in dwarf mice with nonautologous microencapsutated myoblasts - an alternate approach to somatic gene therapy. Hum. Gene Ther. 6, 165-175.
2. AUSUBEL, F.M., BRENT, R., KINGSTON, R.E., MOORE, D.D., SEIDMAN, J.G., SMITH, J.A., and STRUHL, K. (1987). Current Protocols in Molecular Biology. (John Wiley & Sons, New York).
3. BARR, E., and LEIDEN, J.M. (1991). Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254, 1507-1509.
4. BREIER, B.H., GALLAGHER, B.W., and GLUCKMAN, P.D. (1991). Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls. J. Endocrinol. 128, 347-357.
5. CARLSSON, L.M.S., CLARK, R.G., and ROBINSON, I.C.A.F. (1990). Sex differences in growth hormone feedback in the rat. J. Endocrinol. 126, 27-35.
6. CHANG, P.L. (1994). Calcium phosphate-mediated DNA transfection. In Gene Therapeutics: Methods and Applications of Direct Gene Transfer. J.A. Wolff, ed. (Birkhäuser, Boston) pp. 157-179.
7. CHANG, P.L. (1995). Non-autologous somatic gene therapy. In Somatic Gene Therapy. P.L. Chang, ed. (CRC Press Inc., FL), pp. 203-223.
8. CHANG, P.L., CAPONE, J.P., and BROWN, G.M. (1990). Autologous fibroblast implantation - feasibility and potential problems in gene replacement therapy. Mol. Biol. Med. 7, 461-470.
9. CHANG, P.L., SHEN, N., and WESTCOTT, A.J. (1993). Delivery of recombinant gene products with microencapsulated cells in vivo. Hum. Gene Ther. 4, 433-440.
10. CHANG, P.L., HORTELANO, G., TSE, M., and AWREY, D.E. (1994) Growth of recombinant fibroblasts in alginate microcapsules. Biotech. Bioeng. 43, 925-933.
11. D'ERCOLE, A.J., STILES, A.D., and UNDERWOOD, L.E. (1984). Tissue concentration of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc. Natl. Acad. Sci. USA 81, 935-941.
12. DAUGHADAY, W.H., KAPADIA, M., and MARITZ, I. (1987). Serum somatomedin binding proteins: physiologic significance and interference in radioligand assay. J. Lab. Clin. Med. 109, 355-363.
13. DHAWAN, J., PAN, L.C., PAVLATH, G.K., TRAVIS, M.A., LANCTOT, A.M., and BLAU, H.M. (1991). Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254, 1509-1512.
14. DODET, B. (1993). Commercial perspective for gene therapy - a company survey. TIBTECH 11, 182-189.
15. FRASIER, S.D. (1987). Growth hormone deficiency. In Growth Abnormalities. R. Hintz and R. Rosenfeld, eds. (Churchill Livingstone, New York) pp. 41-140.
16. GASSMANN, M., THOMMES, P., WEISER, T., and HUBSCHER, U. (1990). Efficient production of chicken egg yolk antibodies against a conserved mammalian protein. FASEB J. 4, 2528-2532.
17. GUNNING, P., LEAVITT, J., MUSCAT, G., NG, S.-Y., and KEDES, L. (1987). A human β-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA 84, 4831-4835.
18. HUGHES, M., VASSILAKOS, A., ANDREWS, D.W., HORTELANO, G., BELMONT, J.W., and CHANG, P.L. (1994). Delivery of a secretable adenosine deaminase through microcapsules - a novel approach to somatic gene therapy. Hum. Gene Ther. 5, 1445-1455.
19. JAX MICE. (1992). The Jackson Laboratory. Bar Harbor, ME.
20. KAPLAN, S.L. (1993). The newer uses of growth hormone in adults. Adv. Intern. Med. 38, 287-301.
21. KING, G.A., DAUGULIS, A.J., FAULKNER, P., and GOOSEN, M.F.A. (1987). Alginate-polylysine microcapsules of controlled membrane molecular weight cutoff for mammalian cell culture engineering. Biotech. Prog. 3, 231-240.
22. LANZI, R., and TANNENBAUM, G.S. (1992). Time course and mechanism of growth hormone's negative feedback effect on its own spontaneous release. Endocrinology 130, 780-788.
23. LIN, C., LIN, S.-C., CHANG, C.-P., and ROSENFELD, M.G. (1992). Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth. Nature 360, 767-768.
24. LINZER, D.I.H., and TALAMANTES, F. (1985). Nucleotide sequence of mouse prolactin and growth hormone mRNAs and expression of these mRNAs during pregnancy. J. Biol. Chem. 260, 9574-9579.
25. LIU, H.-W., OFOSU, F.A., and CHANG, P.L. (1993). Expression of human factor IX by microencapsulated recombinant fibroblasts. Hum. Gene Ther. 4, 291-301.
26. MACLEOD, J.N., PAMPORI, N.A., and SHAPIRO, B.H. (1991). Sex differences in the ultradian pattern of plasma growth hormone concentration in mice. J. Endocrinol. 131, 395-399.
27. MELDRUM, D.R., CHANG, R.J., LU, J., VALE, W., RIVIER, J., and JUDD, H.L. (1982). Medical oophorectomy using a long-acting Gn-RH agonist: a possible new approach to the treatment of endometriosis. J. Clin. Endocrinol. Metab. 54, 1081-1083.
28. MORGAN, R.A., and ANDERSON, W.F. (1993). Human gene therapy. Annu. Rev. Biochem. 62, 191-217.
29. MORSY, M.A., MITANI, K., CLEMENS, P., and CASKEY, C.T. (1993). Progress toward human gene therapy. J. Am. Med. Assn. 270, 2338-2345.
30. NORSTEDT, G., and PALMITER, R. (1984). Secretory rhythm of growth hormone regulates sexual differentiation of mouse liver. Cell 36, 805-812.
31. PALMITER, R.D., BRINSTER, R.L., HAMMER, R.E., TRUMBAUER, M.E., ROSENFELD, M.G., BIRNBERG, N.C., and EVANS, R.M. (1982). Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 300, 611-615.
32. PALMITER, R.D., NORSTEDT, G., GELINAS, R.E., HAMMER, R.E., and BRINSTER, R.L. (1983). Metallothionein-human GH fusion genes stimulate growth of mice. Science 222, 809-814.
33. SELDEN, R.F., M.J. SKOSKIEWICZ, P.S., RUSSELL, and H.M., GOODMAN (1987). Regulation of insulin-gene expression. N. Engl. J. Med. 317, 1067-1076.
34. TANNENBAUM, G.S. (1987). Interaction of growth hormone-releasing factor and somatostatin in regulation of the rhythmic secretion of growth hormone. In Growth Hormone, Growth Factors, and Acromegaly. D.K. Ludecke and G. Tolis, eds. (Raven Press, New York) pp. 37-54.
35. TANNENBAUM, G.S., and MARTIN, J.B. (1976). Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat. Endocrinology 98, 562-570.
36. VAN WYK, J.J. (1984). The somatomedins: Biological actions and physiologic control mechanisms. In Hormonal proteins and peptides. C.H. Li, ed. (Academic Press, New York) pp. 81-89.
37. VANCE, M.L., KAISER, D.L., EVANS, W.S., FURLANETTO, R., VALE, W., RIVIER, J., and THORNER, M.O. (1985). Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (I-40). J. Clin. Invest. 75, 1584-1590.